The global Clinical Logistics market reached a value of about USD 18.3 billion in 2021. The industry is projected to grow at a CAGR of around 6.8% in the forecast period of 2022-2027 to reach a value of about USD 27.2 billion by 2027.
The global Clinical Logistics industry report gives a comprehensive analysis of the industry, including key segments, trends, drivers, restraints, the competitive landscape, and other essential market aspects. The rise in chronic ailments and increasing clinical trials drive the market's growth. North America is the highest category spender by region that drives the demand for the Clinical Logistics industry.
Clinical logistics comprises Pharmaceuticals, medical and surgical supplies, medical devices and equipment, and other things needed to assist doctors, nurses, and other health and dental care providers. The Clinical Logistics industry report comprises segments by region (North America, Europe, Asia Pacific, the Middle East, and Africa, and South America).
North America holds the largest share in the industry due to the concentration of the pharmaceutical research industry. Furthermore, an increase in the number of clinical trials done by pharmaceutical companies and many market participants is also driving the industry's growth. Also, many research and development projects in advanced health care infrastructure, medication discovery, and the existence of clinical trial organisations around the world are likely to propel the region's development.
The industry is being aided by the rising number of chronic diseases paired with the need to develop effective treatments. Furthermore, the increasing illness complexity, and growing investment in the drug research industry, are expected to drive market expansion. In addition, the importance of fast-track assistance in the medical field and lowering distribution costs by creating a single distribution route is piqueing interest in clinical trial logistics, thus resulting in the market's expansion. Other factors, including the industry's highly regulated structure, globalisation of clinical trials, and an increase in the number of temperature-sensitive product tests, are likely to impact the market positively.
However, factors such as the high initial cost and need for a qualified crew limit the entry of new entrants, thus acting as a market restraint.
The global Clinical Logistics industry report by Procurement Resource gives an in-depth analysis of the best buying practices followed by major global Clinical Logistics regions, such as engagement models, contract terms, and buyer and supplier negotiation levers.
Clinical Logistics is a contract research organisation that assists multinational pharmaceutical and biotech companies execute clinical trials. The services provide specimen collection supplies, create bespoke specimen identification labels and kits, and coordinate, manage, and track specimen transportation. Large biopharmaceutical companies employ clinical logistics organisations (CLOs) and fledgling pharma/biotech companies to maintain the smooth flow of shipments and information and reduce waste and inefficiencies in the worldwide supply chain. Successful CLOs must leverage cutting-edge information, inventory, temperature control, and other technology systems to deliver clinical trial materials on time and within specifications to anywhere in the world.
The market is witnessing growth due to the developments in the sector like smart packaging solutions, such as active and passive thermo-regulated items, guarantee that shipments stay within appropriate temperature ranges while en route and in storage, protecting the shipment's contents is propelling the industry forward. Furthermore, the introduction of new delivery methods, like SENTRY and other GPS-enabled devices, track a shipment's location and condition in real-time, including motion, shock, battery life, and light exposure, and send SMS notifications if there are any deviations or excursions are expected to create new market opportunities. Also, the expanding R&D spending and the number of clinical trials being undertaken internationally paired with the adoption of new technologies in supply chain management by Pharmaceutical and biopharmaceutical companies are likely to drive the market's development.
The regional markets for the industry can be divided into North America, South America, Europe, the Middle East and Africa, and the Asia Pacific.
Intending to strengthen their services, market participants are executing various strategic initiatives, such as new partnership agreements, collaborations, and geographic growth. Moreover, the Logistics businesses are developing strategic alliances with healthcare organisations for improved distribution channels and better reach to clients and outsourcing clinical trial logistics exercises to CROs to increase net revenues and expand the item portfolio to new business sectors.
1. Executive Summary
2. Clinical Logistics Market Snapshot
2.1. Clinical Logistics Market Outlook
2.2. Regional Overview
2.2.1. North America
2.2.3. Asia Pacific
2.2.4. Latin America
2.2.5. Middle East and Africa
3. Key Trends in Application
4. Impact of Recent Events
5. Clinical Logistics Value Chain Analysis
6. Clinical Logistics Production Process
7. Trade Analysis
8. Major Risk Factors in Sourcing
9. Clinical Logistics Cost Structure
10. Clinical Logistics Cost Saving Opportunities
11. Clinical Logistics Price Analysis
12. Key Demand Indicator Analysis
13. Key Price Indicator Analysis
14. Clinical Logistics Market Dynamics
14.1. Drivers & Constraints
14.2. Industry Events
14.3. Swot Analysis
14.4. Porter’s Five Forces
14.4.1. Buyer Power
14.4.2. Supplier Power
14.4.3. Threat of New Entrants
14.4.4. Threat of Substitutes
14.4.5. Industry Rivalry
15. Industry Best Practices
15.1. Sourcing Strategy
15.2. Procurement Model
15.3. Contract Structure
15.4. Negotiation Levers
15.5. Pricing Model
15.6. Key Factors Influencing the Quotation
16. Key Supplier Analysis
16.1. Deutsche Post AG
16.2. Rhenus SE & Co. KG
16.3. Schenker AG
16.4. Ceva Logistics B.V
16.5. Kuehne + Nagel Management AG
The global Clinical Logistics market size was valued at USD 18.3 billion in 2021.
In the forecast period of 2022-2027, the market is projected to grow at a CAGR of 6.8%.
The significant demand for temperature-sensitive medication is one of the essential drivers of the Clinical Logistics market growth.
Deutsche Post AG, Rhenus SE & Co. KG, Schenker AG, Ceva Logistics B.V, and Kuehne + Nagel Management AG are some of the prominent players in the market.
The North American region of the Clinical Logistics industry holds a significant share in the market.
The global Clinical Logistics market attained a value of USD 18.3 billion in 2021, driven by the rising number of chronic diseases paired with the need to develop effective treatments. Aided by the growing developments in the sector like smart packaging solutions, such as active and passive thermo-regulated items, SENTRY, the market is expected to witness further growth in the forecast period of 2022-2027, growing at a CAGR of 6.8%. The market is projected to reach USD 27.2 billion by 2027. Some of the leading players in the industry are Deutsche Post AG, Rhenus SE & Co. KG, Schenker AG, Ceva Logistics B.V, and Kuehne + Nagel Management AG.
Procurement Resources' detailed research approach explores deep into the industry, encompassing the macro and micro aspects of the industry. Its team of experts uses a combination of cutting-edge analytical tools and their expertise, thus, delivering its customers with market insights that are accurate and actionable and help them remain ahead of their competition.
At Procurement Resource our analysts are selected after they are assessed thoroughly on having required qualities so that they can work effectively and productively and are able to execute projects based on the expectations shared by our clients. Our team is hence, technically exceptional, strategic, pragmatic, well experienced and competent.
We understand the cruciality of high-quality assessments that are important for our clients to take timely decisions and plan strategically. We have been continuously upgrading our tools and resources over the past years to become useful partners for our clientele. Our research methods are supported by most recent technology, our trusted and verified databases that are modified as per the needs help us serve our clients effectively every time and puts them ahead of their competitors.
Our team provides a detailed, high quality and deeply researched evaluations in competitive prices, that are unmatchable, and demonstrates our understanding of our client’s resource composition. These reports support our clientele make important procurement and supply chains choices that further helps them to place themselves ahead of their counterparts. We also offer attractive discounts or rebates on our forth coming reports.
Our vision is to enable our clients with superior quality market assessment and actionable evaluations to assist them with taking timely and right decisions. We are always ready to deliver our clients with maximum results by delivering them with customised suggestions to meet their exact needs within the specified timeline and help them understand the market dynamics in a better way.
Email Delivery Price: $ 999.00
The global Artificial Intelligence market reached a value of about USD 192 Billion in 2021. The industry is projected to grow at a CAGR of around 23% in the forecast period of 2022-2027 to reach a value of about USD 664.86 Billion by 2027.Read More
Email Delivery Price: $ 999.00
The global nutmeg market reached a value of about 130 thousand tonnes in 2021. The industry is further expected to grow at a CAGR of about 6% in the forecast period of 2022-2027 to reach a value of around 180 thousand tonnes by 2027.Read More
Email Delivery Price: $ 999.00
The global HEOR market reached a value of about USD 1364.3 million in 2021. The industry is further expected to grow at a CAGR of about 12.81% in the forecast period of 2022-2027 to reach a value of around USD 2779.2 million by 2027.Read More